Medicxi combines six startups to form immuno-dermatology biotech with $100M

European biotech investor Medicxi is bringing six startups under one roof to form an immuno-dermatology drugmaker with 14 pipeline projects in a move reminiscent of its 10-in-1 Centessa Pharmaceuticals unveiling in 2021.

The healthcare investment firm will pump $100 million in financing into the Boston and Geneva-based biotech named Alys…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks